PMDA
- Application: Tagrisso
- Local brand name: Tagrisso
- Status: approved
🇯🇵 Drug: Osimertinib in Japan
Drug: Osimertinib (Drug: Osimertinib) regulatory status in Japan.
Marketing authorisation
Drug: Osimertinib in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Drug: Osimertinib approved in Japan?
Yes. PMDA has authorised it.
Who is the marketing authorisation holder for Drug: Osimertinib in Japan?
Revolution Medicines, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.